tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Daniil Gataulin, 104 are a BUY (85.95%), 17 are a HOLD (14.05%).
Analyst Daniil Gataulin, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 32.16% that have a potential upside of 55.49% achieved within 136 days.
Daniil Gataulin’s has documented 212 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KOD, Kodiak Sciences at 11-May-2026.
Analyst best performing recommendations are on CRVO (CERVOMED).
The best stock recommendation documented was for CRVO (CERVOMED) at 3/13/2025. The price target of $14 was fulfilled within 8 days with a profit of $8.21 (141.8%) receiving and performance score of 177.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
$0.64 (14.68%)
11 months 5 days ago
(17-Nov-2025)
0/5 (0%)
$0.73 (17.10%)
Buy Since 01-Nov-2023
$5.5
$1.14 (26.15%)
$12
11 months 23 days ago
(29-Oct-2025)
1/7 (14.29%)
$1.27 (30.02%)
292
Hold Since 16-Apr-2025
$4
$-0.36 (-8.26%)
$5
11 months 24 days ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
1 years 2 months 9 days ago
(13-Aug-2025)
2/3 (66.67%)
$30.52 (321.94%)
1046
Hold Since 19-Mar-2024
$4
$-0.36 (-8.26%)
$5
1 years 5 months 7 days ago
(15-May-2025)
4/6 (66.67%)
$1.95 (95.12%)
205
Which stock is Daniil Gataulin most bullish on?
What Year was the first public recommendation made by Daniil Gataulin?
